Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Rossari Biotech Ltd ( (IN:ROSSARI) ) just unveiled an announcement.
Rossari Biotech Limited announced its financial results for Q4 and FY25, reporting a 22.6% increase in revenue for Q4 compared to the previous year, reaching Rs. 579.6 crore. The company’s EBITDA improved by 9.3%, while PAT saw a marginal increase of 0.9%. For the full fiscal year, revenue rose by 13.7% to Rs. 2,080.3 crore, with EBITDA and PAT also showing growth. Despite the positive revenue growth, the EBITDA margin saw a slight decline, indicating potential cost pressures.
More about Rossari Biotech Ltd
Rossari Biotech Limited is a specialty chemicals manufacturer that provides intelligent and sustainable solutions for customers across various industries.
YTD Price Performance: -11.81%
Average Trading Volume: 5,429
Current Market Cap: 38.69B INR
Learn more about ROSSARI stock on TipRanks’ Stock Analysis page.